Cargando…
WWL70 protects against chronic constriction injury-induced neuropathic pain in mice by cannabinoid receptor-independent mechanisms
BACKGROUND: Targeting the endocannabinoid system has emerged as an effective strategy for the treatment of inflammatory and neurological diseases. Unlike the inhibition of the principal 2-arachidonyl glycerol (2-AG) hydrolytic enzyme monoacylglycerol lipase (MAGL), which leads to 2-AG overload and c...
Autores principales: | Wen, Jie, Jones, Melissa, Tanaka, Mikiei, Selvaraj, Prabhuanand, Symes, Aviva J., Cox, Brian, Zhang, Yumin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5759843/ https://www.ncbi.nlm.nih.gov/pubmed/29310667 http://dx.doi.org/10.1186/s12974-017-1045-9 |
Ejemplares similares
-
WWL70 attenuates PGE(2) production derived from 2-arachidonoylglycerol in microglia by ABHD6-independent mechanism
por: Tanaka, Mikiei, et al.
Publicado: (2017) -
Therapeutic Effect of the Substrate-Selective COX-2 Inhibitor IMMA in the Animal Model of Chronic Constriction Injury
por: Jones, Melissa, et al.
Publicado: (2018) -
The Novel Monoacylglycerol Lipase Inhibitor MJN110 Suppresses Neuroinflammation, Normalizes Synaptic Composition and Improves Behavioral Performance in the Repetitive Traumatic Brain Injury Mouse Model
por: Selvaraj, Prabhuanand, et al.
Publicado: (2021) -
Therapeutic Effects of Combined Treatment with the AEA Hydrolysis Inhibitor PF04457845 and the Substrate Selective COX-2 Inhibitor LM4131 in the Mouse Model of Neuropathic Pain
por: Wen, Jie, et al.
Publicado: (2023) -
Targeting the endogenous cannabinoid system to treat neuropathic pain
por: Lau, Benjamin K., et al.
Publicado: (2014)